학술논문
Safety, Efficacy, and Pharmacokinetics of Almonertinib (HS-10296) in Pretreated Patients With EGFR-Mutated Advanced NSCLC: A Multicenter, Open-label, Phase 1 Trial
Document Type
Article
Author
Yang, James Chih-Hsin; Camidge, D. Ross; Yang, Cheng-Ta; Zhou, Jianying; Guo, Renhua; Chiu, Chao-Hua; Chang, Gee-Chen; Shiah, Her-Shyong; Chen, Yuan; Wang, Chin-Chou; Berz, David; Su, Wu-Chou; Yang, Nong; Wang, Ziping; Fang, Jian; Chen, Jianhua; Nikolinakos, Petros; Lu, You; Pan, Hongming; Maniam, Ajit; Bazhenova, Lyudmila; Shirai, Keisuke; Jahanzeb, Mohammad; Willis, Maurice; Masood, Nehal; Chowhan, Naveed; Hsia, Te-Chun; Jian, Hong; Lu, Shun
Source
In Journal of Thoracic Oncology December 2020 15(12):1907-1918
Subject
Language
ISSN
1556-0864